XOMA Corporation (XOMA)
NASDAQ
Market Cap
$263.27M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
290 of 809
Rank in Industry
169 of 445
Largest Insider Buys in Sector
XOMA Stock Price History Chart
XOMA Stock Performance
About XOMA Corporation
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Insider Activity of XOMA Corporation
Over the last 12 months, insiders at XOMA Corporation have bought $74,753 and sold $0 worth of XOMA Corporation stock.
On average, over the past 5 years, insiders at XOMA Corporation have bought $6.62M and sold $1.16M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hughes Owen (Exec Chairman and Interim CEO) — $99,810. Sitko Bradley (Chief Investment Officer) — $24,848.
The last purchase of 250 shares for transaction amount of $3,473 was made by Sitko Bradley (Chief Investment Officer) on 2023‑10‑03.
List of Insider Buy and Sell Transactions, XOMA Corporation
| 2023-10-03 | Sitko Bradley | Chief Investment Officer | 250 0.0022% | $13.89 | $3,473 | +55.80% | ||
| 2023-10-02 | Sitko Bradley | Chief Investment Officer | 1,500 0.0133% | $14.25 | $21,375 | +52.74% | ||
| 2023-10-02 | Hughes Owen | Exec Chairman and Interim CEO | 1,000 0.0086% | $13.83 | $13,830 | +52.74% | ||
| 2023-09-26 | Hughes Owen | Exec Chairman and Interim CEO | 2,499 0.0221% | $14.43 | $36,061 | +47.47% | ||
| 2023-09-25 | Hughes Owen | Exec Chairman and Interim CEO | 1 <0.0001% | $14.65 | $15 | +43.00% | ||
| 2023-05-31 | Sitko Bradley | Chief Investment Officer | 1,500 0.0132% | $17.13 | $25,700 | +6.76% | ||
| 2023-05-24 | Hughes Owen | Interim CEO | 1,032 0.012% | $23.79 | $24,551 | +0.22% | ||
| 2023-05-23 | Sitko Bradley | Chief Investment Officer | 850 0.0076% | $19.00 | $16,150 | -4.09% | ||
| 2023-05-23 | Hughes Owen | Interim CEO | 968 0.0107% | $23.46 | $22,706 | -4.09% | ||
| 2023-05-19 | Sitko Bradley | Chief Investment Officer | 1,000 0.0088% | $19.50 | $19,500 | -8.70% | ||
| 2023-05-16 | Sitko Bradley | Chief Investment Officer | 500 0.0049% | $23.20 | $11,602 | -13.17% | ||
| 2023-05-15 | Sitko Bradley | Chief Investment Officer | 1,500 0.0153% | $23.40 | $35,100 | -11.27% | ||
| 2023-05-12 | Sitko Bradley | Chief Investment Officer | 2,000 0.0173% | $18.99 | $37,985 | -7.31% | ||
| 2023-01-06 | BVF PARTNERS L P/IL | director | 3,249 0.0282% | $21.98 | $71,419 | -19.69% | ||
| 2023-01-06 | BVF PARTNERS L P/IL | director | 1,573 0.0137% | $21.98 | $34,577 | -19.69% | ||
| 2023-01-05 | BVF PARTNERS L P/IL | director | 19,000 0.1396% | $18.39 | $349,319 | -18.64% | ||
| 2023-01-05 | BVF PARTNERS L P/IL | director | 15,670 0.1152% | $18.39 | $288,096 | -18.64% | ||
| 2022-07-15 | Sale | Neal James R | CEO | 20,883 0.1824% | $29.55 | $617,095 | -36.18% | |
| 2022-07-15 | Sale | BURNS THOMAS M. | SVP, Finance & CFO | 2,000 0.0187% | $31.66 | $63,321 | -36.18% | |
| 2022-03-21 | Sale | Neal James R | CEO | 2,339 0.021% | $30.02 | $70,209 | -33.94% |
Insider Historical Profitability
21.93%
| Sitko Bradley | Chief Investment Officer | 5600 0.0487% | $22.62 | 8 | 0 | <0.0001% |
| Hughes Owen | Exec Chairman and Interim CEO | 3500 0.0305% | $22.62 | 5 | 0 | <0.0001% |
| BAKER JULIAN | director | 17888512 155.7175% | $22.62 | 1 | 0 | |
| BVF PARTNERS L P/IL | director | 1618637 14.0901% | $22.62 | 48 | 0 | +31.12% |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 326601 2.843% | $22.62 | 0 | 32 | |
| PERRY MATTHEW D | See Explanation of Responses | 200000 1.741% | $22.62 | 1 | 0 | <0.0001% |
| DELLIO CLARENCE L | Sr VP, Operations and COO | 101456 0.8832% | $22.62 | 0 | 4 | |
| DAVIS PETER B | VP, Finance & CFO | 94960 0.8266% | $22.62 | 1 | 0 | <0.0001% |
| BAKER BROS. ADVISORS LP | other | 90538 0.7881% | $22.62 | 1 | 17 | +28.45% |
| KURLAND FRED | CFO & VP Finance | 85086 0.7407% | $22.62 | 1 | 6 | <0.0001% |
| MARGOLIN CHRISTOPHER J | VP, General Counsel & Sec'y | 55687 0.4847% | $22.62 | 0 | 2 | |
| Klein Thomas | Chief Commercial Officer | 43858 0.3818% | $22.62 | 0 | 1 | |
| MENDELL STEVEN C | director | 40000 0.3482% | $22.62 | 0 | 1 | |
| Neal James R | CEO | 15939 0.1387% | $22.62 | 3 | 26 | +31.48% |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 8217 0.0715% | $22.62 | 0 | 26 | |
| BURNS THOMAS M. | SVP, Finance & CFO | 6555 0.0571% | $22.62 | 0 | 15 | |
| BOYLE J DAVID II | VP, Finance, and CFO | 5000 0.0435% | $22.62 | 1 | 0 | +21.99% |
| Varian John | director | 2344 0.0204% | $22.62 | 0 | 34 | |
| ANDRESS JAMES G | director | 2000 0.0174% | $22.62 | 1 | 0 | <0.0001% |
| VAN NESS W DENMAN | director | 0 0% | $22.62 | 0 | 4 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Bvf Inc Il | $87.39M | 31.22 | 3.63M | 0% | +$0 | 0.64 | |
| Fidelity Investments | $27.91M | 9.97 | 1.16M | +0.48% | +$133,886.35 | <0.01 | |
| BlackRock | $11.56M | 4.13 | 480,508 | -1.63% | -$191,846.86 | <0.0001 | |
| The Vanguard Group | $9.75M | 3.48 | 405,533 | -3.78% | -$383,381.02 | <0.0001 | |
| Stonepine Capital Management Llc | $6.1M | 2.18 | 253,770 | +1.51% | +$90,668.51 | 4.93 | |
| Opaleye Management Inc | $6.01M | 2.15 | 250,000 | 0% | +$0 | 0.95 | |
| Geode Capital Management | $4.09M | 1.46 | 170,049 | +5.66% | +$219,193.67 | <0.0001 | |
| Morgan Stanley | $3.83M | 1.37 | 159,183 | +923.88% | +$3.45M | <0.0001 | |
| State Street | $3.34M | 1.19 | 138,949 | +11.68% | +$349,350.25 | <0.0001 | |
| Acuitas Investments, LLC | $2.96M | 1.06 | 123,197 | -10.16% | -$335,136.77 | 1.56 | |
| TLS Advisors LLC | $2.9M | 1.03 | 120,365 | -0.08% | -$2,405.18 | 6.74 | |
| HighVista Strategies | $2.86M | 1.02 | 118,899 | 0% | +$0 | 1.05 | |
| Eversept Partners LP | $2.33M | 0.83 | 97,065 | +3.56% | +$80,278.89 | 0.18 | |
| Northern Trust | $2.07M | 0.74 | 86,096 | -1% | -$20,971.60 | <0.0001 | |
| Woodline Partners LP | $1.73M | 0.62 | 72,106 | +42.62% | +$518,205.26 | 0.02 | |
| BNY Mellon | $1.46M | 0.52 | 60,688 | -3.04% | -$45,719.07 | <0.0001 | |
| Cm Management Llc | $1.32M | 0.47 | 55,000 | 0% | +$0 | 0.06 | |
| RBF Capital, LLC | $736,315.00 | 0.26 | 30,616 | -7.24% | -$57,455.47 | 0.04 | |
| Bridgeway Capital Management | $634,920.00 | 0.23 | 26,400 | -0.75% | -$4,810.00 | 0.01 | |
| Dimensional Fund Advisors | $613,660.00 | 0.22 | 25,516 | 0% | +$0 | <0.0001 | |
| Charles Schwab | $470,418.00 | 0.17 | 19,560 | 0% | +$0 | <0.0001 | |
| Citadel Advisors LLC | $365,801.00 | 0.13 | 15,210 | -42.68% | -$272,414.72 | <0.0001 | |
| Nuveen | $240,211.00 | 0.09 | 9,988 | New | +$240,211.00 | <0.0001 | |
| T. Rowe Price | $212,000.00 | 0.08 | 8,778 | New | +$212,000.00 | <0.0001 | |
| RhumbLine Advisers | $201,073.00 | 0.07 | 8,361 | +2.5% | +$4,905.98 | <0.0001 | |
| UBS | $176,888.00 | 0.06 | 7,355 | -7.43% | -$14,189.52 | <0.0001 | |
| New York State Common Retirement Fund | $136,000.00 | 0.05 | 5,638 | +7.15% | +$9,069.88 | <0.0001 | |
| Barclays | $124,000.00 | 0.04 | 5,161 | -48.84% | -$118,377.83 | <0.0001 | |
| First Manhattan Co. | $120,250.00 | 0.04 | 5,000 | 0% | +$0 | <0.0001 | |
| Deutsche Bank | $111,496.00 | 0.04 | 4,636 | -3.58% | -$4,136.61 | <0.0001 | |
| MetLife Investment Management | $95,238.00 | 0.03 | 3,960 | New | +$95,238.00 | <0.01 | |
| Bank of America | $94,348.00 | 0.03 | 3,923 | -63.02% | -$160,822.09 | <0.0001 | |
| American International Group | $86,652.00 | 0.03 | 3,603 | -0.85% | -$745.55 | <0.0001 | |
| Macquarie Group | $83,000.00 | 0.03 | 3,466 | 0% | +$0 | <0.0001 | |
| JPMorgan Chase | $77,753.00 | 0.03 | 3,233 | -35.24% | -$42,303.60 | <0.0001 | |
| Wells Fargo | $66,798.00 | 0.02 | 2,778 | +13.62% | +$8,007.10 | <0.0001 | |
| Natixis | $41,510.00 | 0.02 | 1,726 | 0% | +$0 | <0.0001 | |
| Citigroup | $32,973.00 | 0.01 | 1,371 | +31.32% | +$7,864.46 | <0.0001 | |
| Royal Bank of Canada | $27,000.00 | 0.01 | 1,123 | -75.04% | -$81,168.30 | <0.0001 | |
| CalSTRS | $17,677.00 | 0.01 | 735 | -38.9% | -$11,255.56 | <0.0001 | |
| Legal & General | $12,771.00 | 0.01 | 531 | -24.89% | -$4,232.95 | <0.0001 | |
| CWM LLC | $14,000.00 | 0.01 | 587 | +0.34% | +$47.70 | <0.0001 | |
| GRP Financial | $14,430.00 | 0.01 | 600 | 0% | +$0 | <0.01 | |
| Ameritas Investment Partners Inc | $14,526.00 | 0.01 | 604 | 0% | +$0 | <0.0001 | |
| MetLife | $9,885.00 | <0.01 | 411 | New | +$9,885.00 | <0.0001 | |
| Tower Research Capital | $10,101.00 | <0.01 | 420 | -35.48% | -$5,555.55 | <0.0001 | |
| Nelson Van Denburg & Campbell Wealth Management Group LLC | $12,049.00 | <0.01 | 501 | 0% | +$0 | <0.01 | |
| Truvestments Capital Llc | $9,620.00 | <0.01 | 400 | 0% | +$0 | <0.01 | |
| Amalgamated Bank | $6,000.00 | <0.01 | 247 | -61.28% | -$9,497.98 | <0.0001 | |
| Advisor Group Holdings Inc | $1,707.00 | <0.01 | 71 | +1.43% | +$24.04 | <0.0001 |